| ISHARES NIKKEI 225 UCITS ETF JPY (ACC) | RVI JAPÓN | 49,72% | 65,08% | 44,69% | 155,31% |
| ISHARES EMERGING MARKETS EQUITY INDEX FUND (LU) X2 EUR CAP | RVI EMERGENTES | 49,70% | 61,03% | 37,08% | · |
| NINETY ONE GSF ASIAN EQUITY FUND J ACC USD | RVI ASIA EX-JAPÓN | 49,70% | 71,75% | 43,79% | · |
| AVIVA INVESTORS - GLOBAL EMERGING MARKETS CORE I USD | RVI EMERGENTES | 49,69% | 60,12% | 34,36% | 85,70% |
| BBVA BOLSA EMERGENTES MF, FI | RVI EMERGENTES | 49,69% | 47,64% | 16,27% | 74,84% |
| AB FCP I-EMERGING MARKETS GROWTH PORTFOLIO B USD | RVI EMERGENTES | 49,68% | 47,90% | 14,02% | 77,58% |
| JPM THEMATICS-GENETIC THERAPIES I (ACC) EUR (HEDGED) | BIOTECNOLOGÍA | 49,68% | 8,86% | -30,03% | · |
| OKAVANGO DELTA, FI A | RV EURO | 49,68% | 126,08% | 143,87% | 90,64% |
| SCHRODER ISF EMERGING ASIA IZ ACC EUR | RVI ASIA | 49,68% | 50,38% | 32,22% | · |
| AMSELECT VONTOBEL GLOBAL EQUITY EMERGING PRIVILEGE DIS | RVI EMERGENTES | 49,66% | 45,81% | · | · |
